MedNAIS app analytics for December 14

MedNAIS

MedNAIS

  • Samplify FZCO
  • Apple App Store
  • Free
  • Medical
MedNAIS™ offers a suite of corporate services designed to meet the unique needs of large healthcare organizations. • Centralized Admin Dashboard: Manage all aspects of the app from a single, user-friendly interface. Assign roles, monitor usage, and control access permissions across your organization. • Custom Reporting & Analytics: Generate custom reports and analyze data based on specific organizational needs, helping you optimize efficiency and compliance. • Custom Branding: Personalize the app with your organization’s branding, creating a seamless experience for your staff. • Online Monitoring of All Users: Real-time tracking of staff activities, ensuring adherence to SOPs and efficient operation. • Corporate Licensing: Flexible licensing options, including volume discounts and access to advanced features tailored to your organization’s size and needs. Why Choose MedNAIS™? MedNAIS™ is designed to bring a new level of precision, compliance, and efficiency to your healthcare operations. Whether you’re managing SOPs, monitoring various procedures, or ensuring the safe transport of samples, MedNAIS™ provides the tools you need to succeed.
MedNAIS

Store Rank

The Store Rank is based on multiple parameters set by Google and Apple.

All Categories in
United States--
Medical in
United States--
Create an account to see avg.monthly downloadsContact us

MedNAIS Ranking Stats Over Time

Similarweb's Usage Rank & Apple App Store Rank for MedNAIS

Rank

No Data Available

MedNAIS Ranking by Country

Counties in which MedNAIS has the highest ranking in its main categories

No Data to Display

Top Competitors & Alternative Apps

Apps with a high probability of being used by the same users, from the same store.

Lifesource Yoga East

Lifesource Yoga East

Lifesource Yoga East, LLC

AidianConnect

AidianConnect

Orion Diagnostica Oy

Vex Fitness

Vex Fitness

Vex Fitness Limited

PAP24

PAP24

CMC M-TECH

MedNAIS VS.

December 14, 2024